Shukra Pharmaceuticals (BOM:524632) Margin of Safety % (DCF Earnings Based): -165.77% (As of Jul. 04, 2026)


BOM:524632 Shukra Pharmaceuticals Ltd BOM:524632
66 GF Score
Price ₹31.68
GF Value ₹8.69
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Shukra Pharmaceuticals Margin of Safety % (DCF Earnings Based)?

Shukra Pharmaceuticals BOM:524632 +7.57% 66 Margin of Safety % (DCF Earnings Based) is -165.77% as of Jul. 04, 2026. GuruFocus rates BOM:524632 with a GF Score™ of 66/100 and a GF Value™ of ₹8.69 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2026-07-04), Shukra Pharmaceuticals's Predictability Rank is 3-Stars. Shukra Pharmaceuticals's intrinsic value calculated from the Discounted Earnings model is ₹11.92 and current share price is ₹31.68. Consequently,

Shukra Pharmaceuticals's Margin of Safety % (DCF Earnings Based) using Discounted Earnings model is -165.77%.

BOM:524632 vs ZTS, UTHR: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Shukra Pharmaceuticals's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shukra Pharmaceuticals Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shukra Pharmaceuticals's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Shukra Pharmaceuticals's Margin of Safety % (DCF Earnings Based) falls into.


BOM:524632
66GF Score
Shukra Pharmaceuticals Ltd BOM:524632
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shukra Pharmaceuticals Margin of Safety % (DCF Earnings Based) Calculation

Shukra Pharmaceuticals's Margin of Safety % (DCF Earnings Based) for today is calculated as

Margin of Safety % (DCF Earnings Based)=(Intrinsic Value: DCF (Earnings Based)-Current Price)/Intrinsic Value: DCF (Earnings Based)
=(11.92-31.68)/11.92
=-165.77 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted Earnings model with default parameters. The calculation method is the same as Discounted Cash Flow model except earnings are used in the calculation instead of free cash flow.

What does a Margin of Safety % (DCF Earnings Based) of -165.77% mean?
Shukra Pharmaceuticals (BOM:524632) has a Margin of Safety % (DCF Earnings Based) of -165.77% as of Jul. 04, 2026. Margin of Safety % (DCF Earnings Based) is the percent difference between the current price and the intrinsic DCF Earnings price. View historical data on Shukra Pharmaceuticals.
Is Shukra Pharmaceuticals' Margin of Safety % (DCF Earnings Based) too high?
Shukra Pharmaceuticals' current Margin of Safety % (DCF Earnings Based) is -165.77%. Overall, Shukra Pharmaceuticals has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shukra Pharmaceuticals' Margin of Safety % (DCF Earnings Based) compare to ZTS and UTHR?
Shukra Pharmaceuticals' Margin of Safety % (DCF Earnings Based) of -165.77% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Margin of Safety % (DCF Earnings Based) for a Drug Manufacturers company?
A good Margin of Safety % (DCF Earnings Based) depends on the Drug Manufacturers industry context. However, Margin of Safety % (DCF Earnings Based) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Margin of Safety % (DCF Earnings Based) mean?
A high Margin of Safety % (DCF Earnings Based) can signal that a stock is expensive relative to its fundamentals. Margin of Safety % (DCF Earnings Based) is the percent difference between the current price and the intrinsic DCF Earnings price. View historical data on Shukra Pharmaceuticals. Shukra Pharmaceuticals's current Margin of Safety % (DCF Earnings Based) is -165.77%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shukra Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Shukra Pharmaceuticals (BOM:524632) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹8.69, compared to a current price of ₹31.68 — trading 264.6% above its estimated fair value. The current Margin of Safety % (DCF Earnings Based) is -165.77%. Shukra Pharmaceuticals' overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Margin of Safety % (DCF Earnings Based) calculated?
Margin of Safety % (DCF Earnings Based) is calculated from a company's financial statements. For Shukra Pharmaceuticals (BOM:524632), the current Margin of Safety % (DCF Earnings Based) is -165.77% as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shukra Pharmaceuticals (BOM:524632) Overvalued in 2026?

Based on GuruFocus' analysis, Shukra Pharmaceuticals stock appears to be overvalued. The current stock price of ₹31.68 is trading 264.6% above its estimated GF Value™ of ₹8.69. GuruFocus considers Shukra Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for BOM:524632:

  • Margin of Safety % (DCF Earnings Based): -165.77%
  • GF Value™: ₹8.69 vs. price of ₹31.68 (264.6% above fair value)
  • GF Score™: 66/100 with 3 warning signs

No single metric tells the full story. See the BOM:524632 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shukra Pharmaceuticals Business Description

Address Judges Bunglow Road, Bodakdev, 3rd Floor, Dev House, Opposite WIAA Office, Ahmedabad, GJ, IND, 380054
Shukra Pharmaceuticals Ltd is engaged in the business of manufacturing and trading pharmaceutical products. The company markets its products in India and international markets. The company has two operating segments: Pharmaceutical and Laboratory. Its product portfolio includes antibiotics, quinolones, macrolides, antibacterials, antifungals, antimalarials, antivirals, antiprotozoals, anthelmintics, antidepressants, antimanics, antiemetics, beta-blockers, analgesics, muscle relaxants, antituberculosis agents, vitamin products, antiallergics, corticosteroids, hyperglycemic and hypoglycemic agents, and others. It exports its products to Australia, Uganda, Kenya, the United Kingdom, Sri Lanka, Mauritius, and the Republic of Yemen.
66GF Score

Get the complete analysis for BOM:524632

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹31.68
Price
₹8.69
GF Value